サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1739179

医療用アイソトープの世界市場

Medical Isotopes

出版日
ページ情報
英文 266 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
医療用アイソトープの世界市場
出版日: 2025年06月03日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 266 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医療用アイソトープの世界市場は2030年までに88億米ドルに達する見込み

2024年に59億米ドルと推定される医療用アイソトープの世界市場は、2024年から2030年にかけてCAGR 6.9%で成長し、2030年には88億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである安定同位体は、CAGR 5.5%を記録し、分析期間終了時には49億米ドルに達すると予測されています。ラジオアイソトープ分野の成長率は、分析期間でCAGR 9.1％と推定されます。

米国市場は16億米ドルと推定、中国はCAGR10.6％で成長予測

米国の医療用アイソトープ市場は2024年に16億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに18億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.6％となります。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.6%と6.7%と予測されています。欧州では、ドイツがCAGR 4.5%で成長すると予測されています。

世界の医療用アイソトープ市場- 主要動向と促進要因のまとめ

なぜ医療用アイソトープが画像診断と標的治療の中心なのか？

医療用アイソトープは、画像診断、標的放射線治療、疾患モニタリングなど幅広い用途で使用されているため、現代のヘルスケアに欠かせないものとなっています。これらの同位体-特定の半減期を持つ放射性原子-は、臓器機能の可視化、腫瘍の検出、代謝活性の評価、治療効果のモニタリングのための核医学的処置においてトレーサーとして使用されます。テクネチウム-99m（Tc-99m）、フッ素-18（F-18）、ヨウ素-131（I-131）、ルテチウム-177（Lu-177）などの主要なアイソトープは、SPECT、PET、放射線治療プロトコールに広く使用されています。

がん、心血管疾患、神経疾患の罹患率の増加に伴い、核医学イメージングに対する需要は着実に増加しており、医療用アイソトープは精密診断の中核を担っています。解剖学的構造を明らかにする従来の画像診断とは異なり、同位体スキャンは生理学的・生化学的情報をリアルタイムで提供するため、早期発見、より正確な病期分類、個別化された治療計画が可能になります。ヘルスケア産業がバリュー・ベース・ケアと個別化医療に軸足を移す中、医療用アイソトープはデータリッチで低侵襲な診断・治療ソリューションの重要な実現者として台頭してきています。

市場の需要に応えるため、生産技術とサプライチェーンモデルはどのように進化しているか？

医療用アイソトープの生産は、世界の需要の高まりに対応し、長年の供給の脆弱性に対処するため、大きな変革期を迎えています。従来は高濃縮ウラン（HEU）を使用する老朽化した原子炉に依存していたアイソトープ生産は、現在では低濃縮ウラン（LEU）ターゲットやサイクロトロン、線形加速器、発電機ベースのシステムなどの原子炉以外の代替手段へと移行しつつあります。この移行は、安全保障上の懸念と、民生用途での兵器級核物質の使用を減らすという規制上の圧力の両方によって推進されています。

サイクロトロン・ベースの製造、特にF-18のような短寿命同位元素の製造は、輸送中の放射性崩壊を最小限に抑え、局所的なヘルスケア・ネットワークにサービスを提供できることから、支持を集めています。モリブデン-99/テクネチウム-99m（Mo-99/Tc-99m）システムのようなジェネレーターベースのソリューションは、現場でのアイソトープ抽出を可能にし、中央集中型のサプライチェーンへの依存を減らします。政府や民間の利害関係者は、バックアップ炉、地域サイクロトロンネットワーク、放射性医薬品製造施設など、アイソトープ供給の弾力性を支えるインフラへの投資を進めています。このような開発により、重要なアイソトープの供給経路は、より安定し、多様化し、スケーラブルになりつつあります。

世界的にアイソトープ利用を牽引している臨床分野とプロシージャ量は？

医療用アイソトープの需要が最も高いのは、腫瘍学、心臓病学、神経学分野です。腫瘍学では、アイソトープは診断（例えば、腫瘍や転移を特定するためのF-18 FDGによるPETイメージング）と治療（例えば、甲状腺がんに対するI-131や前立腺がんに対するLu-177）の両方に使用されています。核医学イメージングによって腫瘍医は、形態学的イメージング技術よりも早く腫瘍の代謝や治療反応を評価することができます。同様に、Tc-99mセスタミビを用いた心臓負荷試験は、冠動脈疾患や心筋灌流障害の検出に役立ち、心血管疾患管理に大きく貢献しています。

神経学的応用は、特にアルツハイマー病、パーキンソン病、てんかんの早期発見のために脚光を浴びています。F-18または炭素ベースの同位体を用いたPET画像は、身体症状が現れる前に脳の活動をマッピングし、神経変性を評価するために使用されています。整形外科や内分泌学では、アイソトープは骨転移や甲状腺機能障害の診断にも役立っています。人口の高齢化が進み、非伝染性疾患が世界的に蔓延する中、核医学の検査件数は、特に外来画像診断センター、がん専門病院、学術研究機関で増加しています。

医療用アイソトープ市場の長期的成長と革新の原動力は？

医療用アイソトープ市場の成長の原動力は、画像診断量の増加、標的核種治療の拡大、規制の近代化、放射性医薬品研究開発の進歩です。診断と治療の機能を単一のアイソトープ・プラットフォームに統合するセラノスティクスの採用が増加しており、商業的にも臨床的にも大きな機会が生まれています。例えば、Lu-177とアクチニウム-225は、転移性がんの画像化と治療の両方のために開発されており、より良い治療マッチングとリアルタイムの反応追跡を可能にしています。

米国DOE/NNSAイニシアティブやEUのHorizonプロジェクトなどの世界の官民パートナーシップは、次世代アイソトープ製造技術や放射性医薬品パイプラインに資金を提供しています。さらに、カナダ、インド、韓国、南アフリカなどの国々は、限られた世界的供給者への依存を減らすため、国内でのアイソトープ生産を拡大しています。新興市場における核医学部門の拡大とPET-CTおよびPET-MRIハイブリッドイメージングシステムの統合が需要を強化しています。

一方、市場間の規制調和と薬局方基準の更新により、新規放射性トレーサーとラベリングキットの承認経路が合理化されつつあります。精密医療と分子診断が進歩し続ける中、医療用アイソトープの戦略的役割はさらに深まり、高性能で個別化されたヘルスケアインフラの礎石として世界的に位置づけられるでしょう。

セグメント

タイプ（安定同位体、放射性同位体）;エンドユーザー（病院、診断センター、調査機関）

調査対象企業の例（注目の32社）

  • ARTMS Inc.
  • Bayer AG
  • Bruce Power
  • BWXT Medical Ltd.
  • Cambridge Isotope Laboratories, Inc.
  • Cardinal Health, Inc.
  • Curium Pharma
  • Eckert & Ziegler
  • GE Healthcare
  • International Isotopes Inc.
  • ITM Isotope Technologies Munich SE
  • Jubilant Radiopharma
  • Lantheus Holdings, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • NTP Radioisotopes SOC Ltd
  • Nusano, Inc.
  • Orano Med
  • SHINE Technologies
  • Sotera Health（Nordion）
  • Theragnostics Ltd

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP34059

Global Medical Isotopes Market to Reach US$8.8 Billion by 2030

The global market for Medical Isotopes estimated at US$5.9 Billion in the year 2024, is expected to reach US$8.8 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Stable Isotopes, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$4.9 Billion by the end of the analysis period. Growth in the Radioisotopes segment is estimated at 9.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 10.6% CAGR

The Medical Isotopes market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 10.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Medical Isotopes Market - Key Trends & Drivers Summarized

Why Are Medical Isotopes Central to Diagnostic Imaging and Targeted Therapeutics?

Medical isotopes have become indispensable to modern healthcare due to their wide-ranging applications in diagnostic imaging, targeted radiotherapy, and disease monitoring. These isotopes-radioactive atoms with specific half-lives-are used as tracers in nuclear medicine procedures to visualize organ function, detect tumors, assess metabolic activity, and monitor treatment efficacy. Key isotopes such as Technetium-99m (Tc-99m), Fluorine-18 (F-18), Iodine-131 (I-131), and Lutetium-177 (Lu-177) are widely deployed in SPECT, PET, and radiotherapeutic protocols.

With the growing incidence of cancer, cardiovascular disease, and neurological disorders, demand for nuclear imaging is increasing steadily, placing medical isotopes at the heart of precision diagnostics. Unlike traditional imaging, which reveals anatomical structure, isotopic scans provide physiological and biochemical information in real time-enabling early detection, more accurate staging, and personalized treatment plans. As the healthcare industry pivots toward value-based care and personalized medicine, medical isotopes are emerging as crucial enablers of data-rich, low-invasiveness diagnostic and therapeutic solutions.

How Are Production Technologies and Supply Chain Models Evolving to Meet Market Demand?

Medical isotope production is undergoing significant transformation to meet rising global demand and address longstanding supply vulnerabilities. Traditionally reliant on aging nuclear reactors using highly enriched uranium (HEU), isotope production is now shifting toward low enriched uranium (LEU) targets and non-reactor alternatives such as cyclotrons, linear accelerators, and generator-based systems. This transition is driven by both security concerns and regulatory pressure to reduce the use of weapons-grade nuclear materials in civilian applications.

Cyclotron-based production, particularly for short-lived isotopes like F-18, is gaining traction due to its ability to serve localized healthcare networks with minimal radioactive decay during transit. Generator-based solutions-such as molybdenum-99/technetium-99m (Mo-99/Tc-99m) systems-enable on-site isotope extraction, reducing dependency on centralized supply chains. Governments and private-sector stakeholders are investing in infrastructure to support isotope supply resilience, including backup reactors, regional cyclotron networks, and radiopharmaceutical manufacturing facilities. These developments are ensuring more stable, diversified, and scalable supply pathways for critical medical isotopes.

Which Clinical Fields and Procedural Volumes Are Driving Isotope Utilization Globally?

The highest demand for medical isotopes originates from oncology, cardiology, and neurology segments. In oncology, isotopes are used in both diagnostics (e.g., PET imaging with F-18 FDG to identify tumors and metastases) and therapeutics (e.g., I-131 for thyroid cancer or Lu-177 for prostate cancer). Nuclear imaging enables oncologists to assess tumor metabolism and treatment response earlier than morphological imaging techniques. Similarly, cardiac stress tests using Tc-99m sestamibi help detect coronary artery disease and myocardial perfusion deficits, contributing significantly to cardiovascular disease management.

Neurological applications are gaining prominence, especially for early detection of Alzheimer’s disease, Parkinson’s disease, and epilepsy. PET imaging with F-18 or carbon-based isotopes is used to map brain activity and evaluate neurodegeneration before physical symptoms manifest. In orthopedics and endocrinology, isotopes also help diagnose bone metastases and thyroid dysfunction. As population aging intensifies and non-communicable diseases become more prevalent globally, procedural volumes for nuclear medicine are rising-particularly in outpatient imaging centers, specialty cancer hospitals, and academic research institutions.

What Is Driving Long-Term Growth and Innovation in the Medical Isotopes Market?

The growth in the medical isotopes market is driven by rising diagnostic imaging volumes, expansion of targeted radionuclide therapy, regulatory modernization, and advancements in radiopharmaceutical R&D. The increasing adoption of theranostics-combining diagnostic and therapeutic capabilities into a single isotope platform-is creating significant commercial and clinical opportunities. For instance, Lu-177 and Actinium-225 are being developed to both image and treat metastatic cancer, allowing for better treatment matching and real-time response tracking.

Global public-private partnerships, such as the U.S. DOE/NNSA initiatives and EU Horizon projects, are funding next-generation isotope production technologies and radiopharmaceutical pipelines. Additionally, countries like Canada, India, South Korea, and South Africa are scaling up domestic isotope production to reduce dependence on limited global suppliers. The expansion of nuclear medicine departments in emerging markets and the integration of PET-CT and PET-MRI hybrid imaging systems are reinforcing demand.

Meanwhile, regulatory harmonization across markets and updated pharmacopoeia standards are streamlining approval pathways for novel radiotracers and labeling kits. As precision medicine and molecular diagnostics continue to advance, the strategic role of medical isotopes will deepen-positioning them as a cornerstone of high-performance, personalized healthcare infrastructure globally.

SCOPE OF STUDY:

The report analyzes the Medical Isotopes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Stable Isotopes, Radioisotopes); End-User (Hospitals, Diagnostic Centers, Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • ARTMS Inc.
  • Bayer AG
  • Bruce Power
  • BWXT Medical Ltd.
  • Cambridge Isotope Laboratories, Inc.
  • Cardinal Health, Inc.
  • Curium Pharma
  • Eckert & Ziegler
  • GE Healthcare
  • International Isotopes Inc.
  • ITM Isotope Technologies Munich SE
  • Jubilant Radiopharma
  • Lantheus Holdings, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • NTP Radioisotopes SOC Ltd
  • Nusano, Inc.
  • Orano Med
  • SHINE Technologies
  • Sotera Health (Nordion)
  • Theragnostics Ltd

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Medical Isotopes - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Nuclear Imaging in Oncology Propels Growth in Medical Isotope Applications
    • Expansion of PET and SPECT Imaging Throws the Spotlight on Short-Lived Radioisotope Production
    • Increased Use of Technetium-99m in Diagnostic Procedures Strengthens Global Market Demand
    • Growth in Targeted Alpha Therapy Accelerates Innovation in Therapeutic Isotope Development
    • Surge in Thyroid and Bone Cancer Cases Drives Use of Iodine-131 and Samarium-153
    • Focus on Cyclotron and Non-Reactor-Based Isotope Production Enhances Supply Chain Resilience
    • Government Support for Domestic Isotope Production Facilities Spurs Regional Capacity Expansion
    • Technological Advancements in Radiopharmaceutical Synthesis Boost Clinical Efficiency
    • Growing Need for Companion Diagnostics Fuels Demand for Theranostic Isotope Pairing
    • Increasing Use of Lutetium-177 in Prostate Cancer Treatment Expands Targeted Radiotherapy Applications
    • Shortage of Reactor-Based Supply Chains Throws the Spotlight on Decentralized Production Models
    • Rising Investment in Cold Kits and Generator-Based Distribution Strengthens Delivery Infrastructure
    • Regulatory Streamlining for Isotope Approvals Accelerates Time-to-Market for Novel Radiotracers
    • Integration of Isotopes in Personalized Medicine Supports Patient-Specific Diagnostic Pathways
    • Emergence of Actinium-225 and Other Alpha Emitters Creates Opportunities in Rare Cancer Treatment
    • Improved Logistics and Half-Life Optimization Techniques Drive Efficiency in Regional Supply Chains
    • Collaboration Between Research Institutions and Pharma Companies Expands Clinical Research Pipeline
    • Use of AI in Radiopharmaceutical Planning Enhances Patient Scheduling and Isotope Utilization
    • Expansion of Radiopharmacy Networks in Emerging Markets Supports Accessibility of Diagnostic Isotopes
    • Global Aging Population and Increased Cancer Screening Rates Sustain Long-Term Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Medical Isotopes Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Medical Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Stable Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Stable Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Stable Isotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Radioisotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • JAPAN
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • CHINA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • EUROPE
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Medical Isotopes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • FRANCE
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • GERMANY
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Medical Isotopes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • INDIA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Medical Isotopes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Medical Isotopes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • AFRICA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION